atossatherapeutics.com Open in urlscan Pro
35.238.218.46  Public Scan

Form analysis
1 forms found in the DOM

GET https://atossatherapeutics.com/

<form role="search" method="get" class="search-form" action="https://atossatherapeutics.com/"><label><span class="screen-reader-text">Search for:</span><input type="search" class="search-field" placeholder="Type and press enter…" value="" name="s"
      title="Search for:"></label></form>

Text Content

 * About Us
 * Articles
 * Breast Cancer Awareness Month
 * Clinical Trials
 * Contact Us
 * Contact Us Old
 * Culture
 * Development Pipeline
 * Home
 * Investors
 * Legal
   * Legal Notice
   * Privacy Policy
 * Sitemap
 * Subscription Confirmed
 * Test1
 * Unsubscribe
 * Videos
 * Vision

Close
Close
Accessibility by WAH
 * 
 * 
 * 

 * Vision
 * Investors
 * Culture

 * About
 * Development Pipeline
 * Clinical Trials
 * Contact Us
 * 
   Search for:


CREATING INNOVATIVE THERAPIES AND NOVEL DELIVERY METHODS


ATOSSA THERAPEUTICS IS A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY SEEKING TO
DISCOVER AND DEVELOP INNOVATIVE MEDICINES IN AREAS OF SIGNIFICANT UNMET MEDICAL
NEED. ATOSSA’S CURRENT FOCUS IS ON BREAST CANCER AND COVID-19.

About Atossa Contact Us



ATOSSA REGULARLY PRODUCES INFORMATIVE VIDEO CONTENT.

View Now


COVID-19 PROGRAMS

Atossa has two programs to develop therapies to treat COVID-19: One called the
COVID-19 HOPE Program which uses AT-H201 for severely ill patients to improve
lung function and reduce the amount of time that COVID-19 patients are on
ventilators and another called AT-301 Nasal Spray for at-home use immediately
following diagnosis of COVID-19 to proactively reduce symptoms of COVID-19 and
to slow the infection rate so that a person’s immune system can more effectively
fight the virus.




TRANSFORMING THE BREAST CANCER PARADIGM

 * ENDOXIFEN
   
   We are developing the promise of endoxifen and exploiting its potential to
   both help prevent as well as to treat breast cancer with our proprietary
   Topical and Oral Endoxifen.

Learn More


ADVANCING
OUR PROGRAMS

We are advancing programs to help develop treatments that are effective and
affordable.

View Product Pipeline



ADVANCING
OUR PROGRAMS

We are advancing programs to help develop treatments that are effective and
affordable.


View Product Pipeline


DEVELOPING SOLUTIONS TO ADDRESS ALL SECTIONS OF THE BREAST CANCER PARADIGM

 * PREVENTION WINDOW
   
   

 * WINDOW-OF-OPPORTUNITY (PRE-SURGERY)
   
   

 * REFRACTORY (POST-SURGERY)
   
   

 * GYNECOMASTIA
   
   

Learn More


A GLOBAL EFFORT

We work with organizations throughout the world to move our programs forward in
an efficient and cost-effective manner.

READ OUR STORY



A GLOBAL EFFORT



We work with organizations throughout the world to move our programs forward in
an efficient and cost-effective manner.

READ OUR STORY


IN THE NEWS

 * Sep 7, 2022
 * Atossa Therapeutics, Inc. to Attend the 24th Annual H.C. Wainwright Global
   Investment Conference
 * Aug 22, 2022
 * Registration Now Open for Tribe Public’s Webinar Event “The Important Role
   For Inhalation Therapy In Oncology” Featuring The Management Team From Atossa
   Therapeutics on August 25, 2022
 * Aug 18, 2022
 * Atossa Therapeutics Appoints Dr. Paul Wabnitz to Its Scientific Advisory
   Board

read all news
 * 
 * 
 * 

 * Presentations
 * Legal
 * Sitemap

Copyright © 2022 Atossa Therapeutics, Inc. All Rights Reserved.


JOIN US


... IN OUR MISSION TO
PREVENT BREAST CANCER

[mailpoet_form id="2"]


EACH AND EVERY EMAIL SIGNUP HELPS US FIGHT THE GOOD FIGHT.

We respect your email privacy. Unsubscribe any time.


We use cookies to ensure that we give you the best experience on our website. If
you continue to use this site we will assume that you are happy with it.Ok